HIV & AIDS

Global Fund secures deal to slash HIV treatment price

The Global Fund announced Wednesday a deal with generic pharmaceutical manufacturers to significantly slash the price of a cutting-edge HIV drug, in a move it said would save lives.

Diseases, Conditions, Syndromes

New animal model shows effective treatment for latent tuberculosis

A major goal of tuberculosis (TB) research is to find a way to treat people with the latent (or inactive) form of the disease to keep them from developing symptomatic TB. A breakthrough study using a new animal model developed ...

HIV & AIDS

New lead against HIV could finally hobble the virus's edge

Since HIV emerged in the '80s, drug "cocktails" transformed the deadly disease into a manageable one. But the virus is adept at developing resistance to drugs, and treatment regimens require tweaking that can be costly. Now ...

page 9 from 39